ADJUVANT HOLDINGS CO., LTD. (4929) AI Stock Analysis

• Market Cap: ¥7.22B
• Dividend Yield: 1.33%
• Average Volume (3M): 41.88K
• Price to Earnings (P/E): 176.8
• Beta (1Y): 0.12
• Revenue Growth: -7.66%
• EPS Growth: N/A
• Country: JP
• Employees: 137
• Sector: Consumer Defensive
• Sector Strength: 55
• Industry: Household & Personal Products
• EPS (TTM): 5.08
• Shares Outstanding: 8,043,600
• 10 Day Avg. Volume: 115,530
• 30 Day Avg. Volume: 41,876
• PEG Ratio: 7.06
• Price to Book (P/B): 1.72
• Price to Sales (P/S): 0.00
• P/FCF Ratio: -18.26
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0

• Rating: 52 Neutral
• Price Target: ¥908.00 ▲(1.00%Upside)

ADJUVANT HOLDINGS CO., LTD. faces significant valuation challenges with its high P/E ratio and overbought technical indicators. While the financial performance shows stability in certain areas, inconsistent revenue growth and profit margins remain issues. The absence of earnings call insights and corporate events further limits positive factors influencing the stock score.

ADJUVANT HOLDINGS CO., LTD. Business Overview & Revenue Model

Company Description

Adjuvant Holdings Co., Ltd. (4929) operates primarily in the cosmetics and healthcare sectors. The company specializes in the development, production, and distribution of beauty products, nutritional supplements, and other health-related goods. Adjuvant Holdings is known for its focus on high-quality ingredients and innovative solutions that promote wellness and enhance beauty.

How the Company Makes Money

Adjuvant Holdings Co., Ltd. generates revenue through the sale of its cosmetics and healthcare products. The company markets its offerings through direct sales, online platforms, and strategic partnerships with retailers and distributors. Key revenue streams include the sale of skincare products, supplements, and other wellness items. Adjuvant Holdings leverages its brand reputation and product quality to attract a loyal customer base and expand its market reach. The company's earnings are further supported by collaborations with research institutions and other industry players to develop advanced formulations and technologies.

ADJUVANT HOLDINGS CO., LTD. Financial Statement Overview

Summary

ADJUVANT HOLDINGS CO., LTD. presents a mixed financial profile. Strong gross margins and a solid balance sheet provide stability, while cash flow efficiency supports operational needs. However, challenges in consistent revenue growth and profit margins suggest areas for improvement. Overall, the company's financial health is sound but requires attention to growth and profitability stability.

Income Statement

The company shows a volatile revenue pattern with a recent decline in revenue growth. The gross profit margin remains healthy, but net profit margins show instability due to fluctuating net income. While EBIT and EBITDA margins have improved recently, historical inconsistency affects overall performance.

Balance Sheet

The balance sheet is strong with a low debt-to-equity ratio, indicating prudent leverage. The equity ratio reflects a solid asset base supported by equity. Return on equity is inconsistent due to fluctuating net income, but the overall position remains stable.

Cash Flow

Cash flow metrics show a moderate performance with fluctuations in free cash flow growth. The operating cash flow to net income ratio is robust, indicating efficient cash generation relative to earnings. However, variability in free cash flow to net income indicates some uncertainty in cash management.

Breakdown	TTM	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021
Income Statement
Total Revenue	5.48B	4.10B	4.44B	4.38B	4.43B	4.89B
Gross Profit	3.56B	2.66B	2.86B	2.92B	2.94B	3.00B
EBITDA	452.89M	259.63M	124.00M	697.06M	500.79M	292.22M
Net Income	147.14M	40.73M	-99.86M	403.64M	393.18M	142.38M
Balance Sheet
Total Assets	5.34B	5.29B	5.28B	5.55B	5.66B	5.10B
Cash, Cash Equivalents and Short-Term Investments	2.11B	2.22B	2.12B	1.53B	1.74B	1.47B
Total Debt	0.00	30.51M	30.82M	19.18M	30.08M	22.96M
Total Liabilities	1.10B	1.11B	1.06B	1.06B	1.34B	1.00B
Stockholders Equity	4.24B	4.18B	4.22B	4.49B	4.32B	4.09B
Cash Flow
Free Cash Flow	54.91M	301.91M	314.89M	-422.66M	369.44M	317.90M
Operating Cash Flow	54.91M	307.99M	377.61M	-321.67M	417.88M	403.11M
Investing Cash Flow	0.00	-95.61M	391.20M	344.97M	24.39M	-235.19M
Financing Cash Flow	0.00	-104.55M	-198.21M	-256.90M	-179.73M	-169.56M

ADJUVANT HOLDINGS CO., LTD. Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 899.00
• 50DMA: Positive
• 100DMA: Positive
• 200DMA: Positive
• MACD: Negative
• RSI: Negative
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:4929, the sentiment is Positive. The current price of 899 is above the 20-day moving average (MA) of 758.35, above the 50-day MA of 760.44, and above the 200-day MA of 795.18, indicating a bullish trend. The MACD of 9.08 indicates Negative momentum. The RSI at 93.02 is Negative, neither overbought nor oversold. The STOCH value of 64.29 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for JP:4929.

ADJUVANT HOLDINGS CO., LTD. Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
4923	73 Outperform	¥42.90B	31.17		1.37%	2.52%	-7.44%
4936	69 Neutral	¥11.43B	55.71		2.11%	4.75%	-83.63%
4934	69 Neutral	¥7.76B	10.65		―	-17.95%	―
Sector *	68 Neutral	¥197.78B	21.08	8.29%	2.34%	4.99%	3.05%
4925	61 Neutral	¥6.19B	10.74		2.44%	-2.13%	―
4929	52 Neutral	¥7.22B	176.82		1.33%	-7.66%	―
4926	45 Neutral	¥4.82B	35.38		1.78%	0.10%	-239.09%